Just to record that I bought my first Amgen (AMGN) shares this morning.
I wrote about Amgen at Seeking Alpha in: Amgen With Onyx Pharmaceuticals: Long-Term Analysis on September 4, 2013. I used to own Onyx Pharmaceuticals; it was one of my best-performing stocks when acquired by Amgen.
While I continue to search for small cap companies with potential therapies that are undervalued, I also think that sometimes larger companies become undervalued. Amgen is making solid profits and has a strong pipeline. For me that adds a lot of diversity. Also, Amgen pays a bit of a dividend, which never hurts.
I'll continue to report on and analyze this company at Amgen Research and Analysis